Refine by
Interventional Procedure Articles & Analysis: Older
40 news found
Around half of all men say lack of sexual function is a significant problem to them after prostate cancer intervention, highlighted in an international survey from 32 countries and over 5000 men by the Europa-Uomo group1. Real world evidence is important to understand what is happening to patients in healthcare2, so AngioDynamics welcomed the news last week that the UK’s ...
(acquired by Cardinal Health in 2014) was founded to address the problem of arterial puncture site closure after interventional procedures. Next came Ocular Therapeutix Inc., to develop an absorbable punctal plug for the extended delivery of drugs to the surface of the eye. ...
PMD announced it will present its first-in-human results for the ModulHeartTM in the following session during the American Heart Association (AHA) meeting held November 5–7, 2022 at the McCormick Place Convention Center in Chicago, IL: Four patients had ModulHeartTM deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention ...
” Amsel Medical’s SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures including ducts – for surgical and interventional procedures. About Amsel Medical Corporation Amsel Medical Corporation is a medical device venture ...
Four patients had ModulHeartTM deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention procedures. All patients experienced improvements in cardiac and kidney function. Additionally, the ModulHeart device was successfully deployed, activated, and removed, with no procedural or device-related ...
"The mortality due to exsanguination associated with junctional and non-compressible hemorrhage in the battlefield prior to surgical intervention is extremely high, with a greater than 60 percent mortality amongst US combatants," said Col(ret). ...
Four patients had ModulHeart deployed to provide circulatory support while undergoing high-risk percutaneous coronary intervention (PCI) procedures. All patients experienced improvements in cardiac and kidney function. Additionally, the ModulHeart device was successfully deployed, activated, and removed, with no procedural or device-related ...
He was the first vascular surgeon in the U.S. to perform two breakthrough procedures for treating venous disease. “Dr. Lowell Kabnick is a key thought leader in vascular medicine and pioneer of many innovations that underpin today’s clinical practice,” said Amsel Medical CEO David Doster. ...
We are committed every day, with enthusiasm and great passion, to bring to every angiography room a reliable, safe and validated technology for carrying out diagnostic and interventional procedures, and for safeguarding the renal function of ...
Retrievable filters partially address these concerns, but retrieval procedures are costly, complex, and frequently delayed. Adient addresses the root cause of these issues through a filter that serves its purpose, then simply vanishes without the need for additional intervention." About Cordis Cordis is a worldwide leader in the development and manufacturing ...
” Amsel Medical’s SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures including ducts – for surgical and interventional procedures. About Amsel Medical Corporation Amsel Medical Corporation is a medical device venture ...
” 2022 ARVO Presentation Highlights Summary of Safety Results All 24 treated patients reported at least one adverse event (AE) and at least one ocular AE The majority of AEs reported with OpRegen were mild (Cohort 1-3, 87%; Cohort 4, 93%), and the immunosuppressive regimen was well tolerated Ocular AEs observed with OpRegen were mainly related to the surgical ...
” It is well established that interventional procedures expose patients and staff to high levels of radiation. ...
” Amsel Medical’s SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures including ducts – for surgical and interventional procedures. About Amsel Medical Corporation Amsel Medical Corporation is a medical device venture ...
“Temporary mechanical support enables a high-risk patient to undergo necessary interventions that their heart would otherwise not be able to tolerate. Despite current offerings, there is significant opportunity for further innovation in this large and growing market,” stated Bihua Chen, Founder and Managing Member of Cormorant Asset Management. ...
Yundai Chen, a renowned interventional cardiologist and author of several scientific publications. This robotic assisted procedure is the first intervention within a clinical study carried out by CathBot; a joint venture between Robocath and MedBot (the robot-focused subsidiary of MicroPort Scientific Corporation). ...
ByRobocath
” Chronic rhinosinusitis is one of the most common chronic medical conditions worldwide, affecting all age groups, with an estimated incidence of nearly 11% in Europe.i Of those in the UK with chronic sinusitis, approximately 15 percent undergo sinus surgery yearly after failing medical treatment.ii Quality of life scores of patients with chronic sinusitis are significantly lower than in ...
All of these TULSA-PRO® systems will be placed under Profound’s per procedure business model. The initial geographic focus of the relationship will be in the State of Florida, with Texas and Pennsylvania expected to follow. ...
R-One is a robotic platform that assists interventional cardiologists in performing coronary angioplasties. This procedure consists in revascularizing the cardiac muscle, by inserting one or more implants (stents) into the arteries that supply it with blood. ...
ByRobocath
B. Braun Interventional Systems Inc. (BIS) announced today that they will collaborate with Infraredx, a Nipro Company, to accelerate the U.S. ...